Cargando…
Assessment of the Concordance and Diagnostic Accuracy Between Elecsys and Lumipulse Fully Automated Platforms and Innotest
Manual ELISA assays are the most commonly used methods for quantification of biomarkers; however, they often show inter- and intra-laboratory variability that limits their wide use. Here, we compared the Innotest ELISA method with two fully automated platforms (Lumipulse and Elecsys) to determine wh...
Autores principales: | Dakterzada, Farida, López-Ortega, Ricard, Arias, Alfonso, Riba-Llena, Iolanda, Ruiz-Julián, Maria, Huerto, Raquel, Tahan, Nuria, Piñol-Ripoll, Gerard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970049/ https://www.ncbi.nlm.nih.gov/pubmed/33746733 http://dx.doi.org/10.3389/fnagi.2021.604119 |
Ejemplares similares
-
Alzheimer’s cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans: CSF AD biomarkers measured by Lumipulse in Koreans
por: Moon, Sohee, et al.
Publicado: (2021) -
Changes in Plasma Neutral and Ether-Linked Lipids Are Associated with The Pathology and Progression of Alzheimer’s Disease
por: Dakterzada, Farida, et al.
Publicado: (2023) -
Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status
por: Willemse, Eline A. J., et al.
Publicado: (2021) -
Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s disease
por: Wilson, Edward N., et al.
Publicado: (2022) -
Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imaging
por: Doecke, James D., et al.
Publicado: (2020)